Literature DB >> 23110824

Harnessing the power of metabolism for seizure prevention: focus on dietary treatments.

Adam L Hartman1, Carl E Stafstrom.   

Abstract

The continued occurrence of refractory seizures in at least one-third of children and adults with epilepsy, despite the availability of almost 15 conventional and novel anticonvulsant drugs, speaks to a dire need to develop novel therapeutic approaches. Cellular metabolism, the critical pathway by which cells access and utilize energy, is essential for normal neuronal function. Furthermore, mounting evidence suggests direct links between energy metabolism and cellular excitability. The high-fat, low-carbohydrate ketogenic diet has been used as a treatment for drug-refractory epilepsy for almost a century. Yet, the multitude of alternative therapies to target aspects of cellular metabolism and hyperexcitability is almost untapped. Approaches discussed in this review offer a wide diversity of therapeutic targets that might be exploited by investigators in the search for safer and more effective epilepsy treatments.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23110824      PMCID: PMC3562425          DOI: 10.1016/j.yebeh.2012.09.019

Source DB:  PubMed          Journal:  Epilepsy Behav        ISSN: 1525-5050            Impact factor:   2.937


  120 in total

Review 1.  Modulation of oxidative stress and mitochondrial function by the ketogenic diet.

Authors:  Julie Milder; Manisha Patel
Journal:  Epilepsy Res       Date:  2011-11-09       Impact factor: 3.045

2.  Dietary approaches to epilepsy treatment: old and new options on the menu.

Authors:  Carl E Stafstrom
Journal:  Epilepsy Curr       Date:  2004 Nov-Dec       Impact factor: 7.500

3.  Ketogenic diet also benefits Dravet syndrome patients receiving stiripentol: a prospective pilot study.

Authors:  Rima Nabbout; Cristiana Copioli; Mathilde Chipaux; Nicole Chemaly; Isabelle Desguerre; Olivier Dulac; Catherine Chiron
Journal:  Epilepsia       Date:  2011-05-13       Impact factor: 5.864

4.  Pharmacological modulation of central monoaminergic systems and influence on the anticonvulsant effectiveness of standard antiepileptics in maximal electroshock seizure.

Authors:  W Fischer; M Müller
Journal:  Biomed Biochim Acta       Date:  1988

Review 5.  Clinical aspects of the ketogenic diet.

Authors:  Adam L Hartman; Eileen P G Vining
Journal:  Epilepsia       Date:  2007-01       Impact factor: 5.864

6.  BAD-dependent regulation of fuel metabolism and K(ATP) channel activity confers resistance to epileptic seizures.

Authors:  Alfredo Giménez-Cassina; Juan Ramón Martínez-François; Jill K Fisher; Benjamin Szlyk; Klaudia Polak; Jessica Wiwczar; Geoffrey R Tanner; Andrew Lutas; Gary Yellen; Nika N Danial
Journal:  Neuron       Date:  2012-05-24       Impact factor: 17.173

Review 7.  Calorie restriction and glucose regulation.

Authors:  Kelvin A Yamada
Journal:  Epilepsia       Date:  2008-11       Impact factor: 5.864

Review 8.  Glucose transporter deficiency syndrome (GLUT1DS) and the ketogenic diet.

Authors:  Jörg Klepper
Journal:  Epilepsia       Date:  2008-11       Impact factor: 5.864

9.  Neuronal-glial interactions in rats fed a ketogenic diet.

Authors:  Torun Margareta Melø; Astrid Nehlig; Ursula Sonnewald
Journal:  Neurochem Int       Date:  2006-03-20       Impact factor: 3.921

Review 10.  The neuropharmacology of the ketogenic diet.

Authors:  Adam L Hartman; Maciej Gasior; Eileen P G Vining; Michael A Rogawski
Journal:  Pediatr Neurol       Date:  2007-05       Impact factor: 3.372

View more
  8 in total

1.  Glycolysis Inhibition: The Gift of GAB(A).

Authors:  Adam L Hartman
Journal:  Epilepsy Curr       Date:  2017 Mar-Apr       Impact factor: 7.500

Review 2.  Ketogenic diets, mitochondria, and neurological diseases.

Authors:  Lindsey B Gano; Manisha Patel; Jong M Rho
Journal:  J Lipid Res       Date:  2014-05-20       Impact factor: 5.922

3.  d-Leucine: Evaluation in an epilepsy model.

Authors:  Kylie Holden; Adam L Hartman
Journal:  Epilepsy Behav       Date:  2017-11-07       Impact factor: 2.937

4.  Potent anti-seizure effects of D-leucine.

Authors:  Adam L Hartman; Polan Santos; Kenneth J O'Riordan; Carl E Stafstrom; J Marie Hardwick
Journal:  Neurobiol Dis       Date:  2015-06-06       Impact factor: 5.996

5.  Old-onset caloric restriction effects on neuropeptide Y- and somatostatin-containing neurons and on cholinergic varicosities in the rat hippocampal formation.

Authors:  Armando Cardoso; Diogo Silva; Sara Magano; Pedro A Pereira; José P Andrade
Journal:  Age (Dordr)       Date:  2014-12-04

6.  Metabolic therapy with Deanna Protocol supplementation delays disease progression and extends survival in amyotrophic lateral sclerosis (ALS) mouse model.

Authors:  Csilla Ari; Angela M Poff; Heather E Held; Carol S Landon; Craig R Goldhagen; Nicholas Mavromates; Dominic P D'Agostino
Journal:  PLoS One       Date:  2014-07-25       Impact factor: 3.240

Review 7.  Bioenergetic Mechanisms of Seizure Control.

Authors:  Richard Kovács; Zoltan Gerevich; Alon Friedman; Jakub Otáhal; Ofer Prager; Siegrun Gabriel; Nikolaus Berndt
Journal:  Front Cell Neurosci       Date:  2018-10-08       Impact factor: 5.505

8.  Incidence and Characteristics of Kidney Stones in Patients on Ketogenic Diet: A Systematic Review and Meta-Analysis.

Authors:  Prakrati Acharya; Chirag Acharya; Charat Thongprayoon; Panupong Hansrivijit; Swetha R Kanduri; Karthik Kovvuru; Juan Medaura; Pradeep Vaitla; Desiree F Garcia Anton; Poemlarp Mekraksakit; Pattharawin Pattharanitima; Tarun Bathini; Wisit Cheungpasitporn
Journal:  Diseases       Date:  2021-05-25
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.